Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a

Abstract

Glycogen storage disease (GSD) 0a is a rare congenital metabolic disease with symptoms in infancy and childhood caused by biallelic GYS2 germline variants. A predisposition to cancer has not been described yet. We report here a boy with GSD 0a, who developed a malignant brain tumor at the age of 4.5 years. The tumor was classified as a group 3 medulloblastoma, and the patient died from cancer 27 months after initial tumor diagnosis. This case appears interesting as group 3 medulloblastoma is so far not known to arise in hereditary syndromes and the biology of sporadic group 3 medulloblastoma is largely unknown.

Bibliografische Daten

OriginalspracheEnglisch
ISSN0256-7040
DOIs
StatusVeröffentlicht - 03.2018
PubMed 29167993